The plant investigation is in process.
A supplemental mdr will be submitted upon completion of this activity.
Clinical investigation: a temporal relationship exists between a blood leak occurring with the fresenius optiflux 160nre dialyzer during this patient¿s hd treatment and subsequent blood loss (approximately 250cc) with associated itching which was resolved via treatment with intravenous (iv) benadryl on an outpatient basis.
However, a causal relationship could not be determined.
The patient was able to complete their regularly scheduled hd treatment without any further adverse events/hospitalization.
The optiflux dialyzer manufacturer instructions for use cautions that blood leaks can occur during treatment which can lead to patient blood loss.
Therefore, a causal/contributory relation cannot be excluded.
Currently, there is no allegation of any visual defects or product deficiency with the fresenius optiflux 160nre dialyzer that led to the reported blood leak.
Reportedly, the patient has since continued their regularly scheduled hd therapy with the same brand dialyzer without any further issues or complaints of itching.
|
A user facility biomedical technician (biomed) reported to fresenius customer service that a dialyzer blood leak occurred during a patient¿s hemodialysis (hd) treatment and that the patient complained of itching.
Additional information was obtained through follow-up with the facility¿s clinical manager (cm).
The dialyzer used for the treatment was reportedly primed, per clinic protocol.
There were no visual defects noted on the device prior to use.
After treatment began (time not specified), the dialysis machine alarmed with a blood leak alert and blood was visible in the dialysate line (as expected).
The patient¿s hd treatment was discontinued temporarily.
The patient¿s blood was not rinsed back, per clinic protocol.
Therefore, the patient lost approximately 250 cc of blood.
The patient¿s vitals remained normal and the patient did not have any serious injuries due to the reported blood loss.
However, the patient did complain of itching near the scapula area, stomach, and legs post-incident.
As a result, the patient¿s nephrologist ordered benadryl intravenously which resolved the patient¿s itch.
The patient completed their treatment with a new dialysis set up, without any harm incurred.
The patient did not require hospitalization.
The patient has continued their regularly scheduled hd therapy with the same brand dialyzer without any further issues or complaints (including itching).
The dialyzer was reported to be available for manufacturer evaluation.
|